Search Results - "Taïeb, David"

New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification by Crona, Joakim, Taïeb, David, Pacak, Karel

“…Abstract A molecular biology–based taxonomy has been proposed for pheochromocytoma and paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed…”
Get full text

Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups by Taïeb, David, Jha, Abhishek, Treglia, Giorgio, Pacak, Karel

“…In recent years, advancement in genetics has profoundly helped to gain a more comprehensive molecular, pathogenic, and prognostic picture of pheochromocytomas…”
Get full text

European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma by Taïeb, David, Hicks, Rodney J., Hindié, Elif, Guillet, Benjamin A., Avram, Anca, Ghedini, Pietro, Timmers, Henri J., Scott, Aaron T., Elojeimy, Saeed, Rubello, Domenico, Virgolini, Irène J., Fanti, Stefano, Balogova, Sona, Pandit-Taskar, Neeta, Pacak, Karel

“…Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging, and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond…”
Get full text

Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions by Deroose, Christophe M, Hindié, Elif, Kebebew, Electron, Goichot, Bernard, Pacak, Karel, Taïeb, David, Imperiale, Alessio

“…Through diagnostic imaging and peptide receptor radionuclide therapy, nuclear medicine has earned a major role in gastroenteropancreatic neuroendocrine tumors…”
Get full text

Genetic Determinants of Pheochromocytoma and Paraganglioma Imaging Phenotypes by Taïeb, David, Pacak, Karel

“…Parallel to the application of new PET radiopharmaceuticals for pheochromocytoma and paraganglioma (collectively named PPGLs) imaging, several studies have…”
Get full text

Pheochromocytoma (PHEO) and Paraganglioma (PGL) by Pacak, Karel, Taïeb, David

“…This series of 23 articles (17 original articles, six reviews) is presented by international leaders in pheochromocytoma and paraganglioma (PPGL) [...]…”
Get full text

High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma by Jha, Abhishek, Taïeb, David, Carrasquillo, Jorge A., Pryma, Daniel A., Patel, Mayank, Millo, Corina, de Herder, Wouter W., Del Rivero, Jaydira, Crona, Joakim, Shulkin, Barry L., Virgolini, Irene, Chen, Alice P., Mittal, Bhagwant R., Basu, Sandip, Dillon, Joseph S., Hope, Thomas A., Mari Aparici, Carina, Iagaru, Andrei H., Hicks, Rodney J., Avram, Anca M., Strosberg, Jonathan R., Civelek, Ali Cahid, Lin, Frank I., Pandit-Taskar, Neeta, Pacak, Karel

“…Abstract Targeted radionuclide therapies (TRT) using 131I-metaiodobenzylguanidine (131I-MIBG) and peptide receptor radionuclide therapy (177Lu or 90Y)…”
Get full text

Editorial: Pediatric adrenal neoplasms by Pamporaki, Christina, Redlich, Antje, Taïeb, David, Pacak, Karel

Get full text

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer by Leboulleux, Sophie, Do Cao, Christine, Zerdoud, Slimane, Attard, Marie, Bournaud, Claire, Lacroix, Ludovic, Benisvy, Danielle, Taïeb, David, Bardet, Stéphane, Terroir-Cassou-Mounat, Marie, Anizan, Nadège, Bouvier-Morel, Emilie, Lamartina, Livia, Lion, Georges, Betrian, Sarah, Sajous, Christophe, Schiazza, Aurélie, Garcia, Marie-Eve, Ciappuccini, Renaud, Schlumberger, Martin, Al Ghuzlan, Abir, Godbert, Yann, Borget, Isabelle

“…To evaluate the efficacy and safety of dabrafenib-trametinib-131I for the treatment of radioactive iodine refractory metastatic differentiated thyroid cancer…”
Get full text

Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms by Fargette, Christelle, Shulkin, Barry, Jha, Abhishek, Pacak, Karel, Taïeb, David

“…Adrenal neoplasms rarely occur in children. They can be diagnosed in the presence of endocrine, metabolic or neurological problems, an abdominal mass, more…”
Get full text

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors by Hope, Thomas A, Allen-Auerbach, Martin, Bodei, Lisa, Calais, Jeremie, Dahlbom, Magnus, Dunnwald, Lisa K, Graham, Michael M, Jacene, Heather A, Heath, Courtney Lawhn, Mittra, Erik S, Wright, Chadwick L, Fendler, Wolfgang P, Herrmann, Ken, Taïeb, David, Kjaer, Andreas

Get full text

Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity by Cherif, Chaïma, Nguyen, Dang Tan, Paris, Clément, Le, Thi Khanh, Sefiane, Thibaud, Carbuccia, Nadine, Finetti, Pascal, Chaffanet, Max, kaoutari, Abdessamad El, Vernerey, Julien, Fazli, Ladan, Gleave, Martin, Manai, Mohamed, Barthélémy, Philippe, Birnbaum, Daniel, Bertucci, François, Taïeb, David, Rocchi, Palma

“…Disease progression and therapeutic resistance of prostate cancer (PC) are linked to multiple molecular events that promote survival and plasticity. We…”
Get full text

Somatostatin Receptor Theranostics for Refractory Meningiomas by Salgues, Betty, Graillon, Thomas, Horowitz, Tatiana, Chinot, Olivier, Padovani, Laetitia, Taïeb, David, Guedj, Eric

“…Somatostatin receptor (SSTR)-targeted peptide receptor radionuclide therapy (PRRT) represents a promising approach for treatment-refractory meningiomas…”
Get full text

International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers by Amar, Laurence, Pacak, Karel, Steichen, Olivier, Akker, Scott A., Aylwin, Simon J. B., Baudin, Eric, Buffet, Alexandre, Burnichon, Nelly, Clifton-Bligh, Roderick J., Dahia, Patricia L. M., Fassnacht, Martin, Grossman, Ashley B., Herman, Philippe, Hicks, Rodney J., Januszewicz, Andrzej, Jimenez, Camilo, Kunst, Henricus P. M., Lewis, Dylan, Mannelli, Massimo, Naruse, Mitsuhide, Robledo, Mercedes, Taïeb, David, Taylor, David R., Timmers, Henri J. L. M., Treglia, Giorgio, Tufton, Nicola, Young, William F., Lenders, Jacques W. M., Gimenez-Roqueplo, Anne-Paule, Lussey-Lepoutre, Charlotte

“…Approximately 20% of patients diagnosed with a phaeochromocytoma or paraganglioma carry a germline mutation in one of the succinate dehydrogenase ( SDHx )…”
Get full text

Targeting NAD + /PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB -Mutated Cluster I Pheochromocytoma and Paraganglioma by Pang, Ying, Lu, Yanxin, Caisova, Veronika, Liu, Yang, Bullova, Petra, Huynh, Thanh-Truc, Zhou, Yiqiang, Yu, Di, Frysak, Zdenek, Hartmann, Igor, Taïeb, David, Pacak, Karel, Yang, Chunzhang

“…Cluster I pheochromocytomas and paragangliomas (PCPGs) tend to develop malignant transformation, tumor recurrence, and multiplicity. Transcriptomic profiling…”
Get full text

Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma by Pamporaki, Christina, Prodanov, Tamara, Meuter, Leah, Berends, Annika M.A., Bechmann, Nicole, Constantinescu, Georgiana, Beuschlein, Felix, Remde, Hanna, Januszewicz, Andrzej, Kerstens, Michiel N., Timmers, Henri J.L.M., Taïeb, David, Robledo, Mercedes, Lenders, Jacques W.M., Pacak, Karel, Eisenhofer, Graeme

“…Pheochromocytomas and paragangliomas (PPGLs) have a heterogeneous prognosis, the basis of which remains unclear. We, therefore, assessed disease-specific…”
Get full text

Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs by Baylot, Virginie, Le, Thi Khanh, Taïeb, David, Rocchi, Palma, Colleaux, Laurence

“…Rare diseases (RD) affect a small number of people compared to the general population and are mostly genetic in origin. The first clinical signs often appear…”
Get full text

Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option by Clerc, Jérôme, Verburg, Frederik A., Avram, Anca M., Giovanella, Luca, Hindié, Elif, Taïeb, David

Get full text

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer by Le, Thi Khanh, Cherif, Chaïma, Omabe, Kenneth, Paris, Clément, Lannes, François, Audebert, Stéphane, Baudelet, Emilie, Hamimed, Mourad, Barbolosi, Dominique, Finetti, Pascal, Bastide, Cyrille, Fazli, Ladan, Gleave, Martin, Bertucci, François, Taïeb, David, Rocchi, Palma

“…The heat shock protein 27 (Hsp27) has emerged as a principal factor of the castration-resistant prostate cancer (CRPC) progression. Also, an antisense…”
Get full text

A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas by Imperiale, Alessio, Moussallieh, François-Marie, Sebag, Frédéric, Brunaud, Laurent, Barlier, Anne, Elbayed, Karim, Bachellier, Philippe, Goichot, Bernard, Pacak, Karel, Namer, Izzie-Jacques, Taïeb, David

“…Paragangliomas (PGLs) are frequently associated with germline mutations in genes involved in energy metabolism. The purpose of the present study was to assess…”
Get full text